This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.Find sources: "ArthroCare" – news · newspapers · books · scholar · JSTOR (April 2011) (Learn how and when to remove this template message) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "ArthroCare" – news · newspapers · books · scholar · JSTOR (April 2011) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

ArthroCare (NASDAQ: ARTC) is a United States-based public company in the field of medical devices.[1] The prime focus of the company is soft tissue repair and ablation technology in the medical areas of larger joints (knee, hip, and shoulder), spine as well as ENT.

Controversies

In 2008, several class actions were filed against ArthroCare, alleging that ArthroCare issued materially false and misleading statements and failed to disclose some adverse facts. In 2012, a settlement of $74 million was approved.[2]

References

  1. ^ Dealbook (18 August 2009). "One Equity Partners has signed an agreement with ArthroCare that will provide the latter with a $75 million infusion". The New York Times. Retrieved 2011-04-01.
  2. ^ "Class Action Lawsuit Against ArthroCare". Archived from the original on 2013-06-19.

External links


Categories